Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:37 pm Sale | 2026-06-30 | 13G | ATRIUM THERAPEUTICS INC RNA | RA Capital Management, L.P. | 0 0.000% | -864,102 (Position Closed) | Filing History |
| 2026-08-14 4:07 pm Purchase | 2026-06-30 | 13G | ATRIUM THERAPEUTICS INC RNA | Sessa Capital IM, L.P. | 1,500,000 8.800% | 1,500,000 (New Position) | Filing History |
| 2026-08-14 10:38 am Sale | 2026-06-30 | 13G | ATRIUM THERAPEUTICS INC RNA | T. Rowe Price Associates, Inc. | 1,472,984 8.600% | -80,226 (-5.17%) | Filing History |
| 2026-07-27 4:25 pm Purchase | 2026-06-30 | 13G | ATRIUM THERAPEUTICS INC RNA | BlackRock Inc. BLK | 1,135,757 6.600% | 243,370 (+27.27%) | Filing History |
| 2026-05-15 4:32 pm Purchase | 2026-03-31 | 13G | ATRIUM THERAPEUTICS INC RNA | RA Capital Management, L.P. | 864,102 5.600% | 864,102 (New Position) | Filing History |
| 2026-04-27 4:12 pm Purchase | 2026-03-31 | 13G | ATRIUM THERAPEUTICS INC RNA | BlackRock Inc. BLK | 892,387 5.200% | 892,387 (New Position) | Filing History |
| 2026-04-08 3:25 pm Purchase | 2026-03-31 | 13G | ATRIUM THERAPEUTICS INC RNA | T. Rowe Price Associates, Inc. | 1,553,210 10.000% | 1,553,210 (New Position) | Filing History |